Co-Diagnostics, Inc.

Co-diagnostics, Inc.

Medical Devices • Healthcare • Salt Lake City, UT, United States • CODX (NCM)

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.

801 438 1036 2401 S. Foothill Dr., Salt Lake City, UT 84109, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Co-Diagnostics Announces Reverse Stock Split - PR Newswire
PR Newswire • Dec 30
CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform - Yahoo Finance
Yahoo Finance • Dec 31
Co-Diagnostics stock plunges after announcing 1-for-30 reverse split - Investing.com
Investing.com • Dec 30
Biotech Co-Diagnostics shrinks share count 30-to-1 to stay on Nasdaq - Stock Titan
Stock Titan • Dec 30
CODX Stock Plunges To All-Time Lows On 1-for-30 Reverse Stock Split Approval - Stocktwits
Stocktwits • Dec 30

Other Medical Devices Companies

View All →
ABBOTT LABORATORIES logo Abbott Laboratories
$218.91B market cap
BOSTON SCIENTIFIC CORP logo Boston Scientific Corp.
$142.40B market cap
STRYKER CORP logo Stryker Corp.
$135.46B market cap
Medtronic plc logo Medtronic PLC
$123.80B market cap
Edwards Lifesciences Corp logo Edwards Lifesciences Corp.
$51.04B market cap
DEXCOM INC logo Dexcom Inc.
$26.50B market cap

Frequently Asked Questions

Has Co-Diagnostics, Inc. had layoffs?
No layoff events have been recorded for Co-Diagnostics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Co-Diagnostics, Inc. have?
Co-Diagnostics, Inc. has approximately 132 employees.
What industry is Co-Diagnostics, Inc. in?
Co-Diagnostics, Inc. operates in the Medical Devices industry, within the Healthcare sector.
Is Co-Diagnostics, Inc. a publicly traded company?
Yes, Co-Diagnostics, Inc. is publicly traded under the ticker symbol CODX on the NCM. The company has a market capitalization of approximately $0.01 billion.
Where is Co-Diagnostics, Inc. headquartered?
Co-Diagnostics, Inc. is headquartered in Salt Lake City, UT, United States at 2401 S. Foothill Dr., Salt Lake City, UT 84109, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.